Zobrazeno 1 - 6
of 6
pro vyhledávání: '"George H. Klinger"'
Autor:
Atsushi Nakajima, Arun J. Sanyal, Johanna R Mora, Brent A. Neuschwander-Tetri, Edgar D. Charles, Rohit Loomba, Stephen A. Harrison, Giridhar S. Tirucherai, Diane E. Shevell, Shuyan Du, Zachary Goodman, George H. Klinger, Masayuki Yamaguchi, Richard A. Ehman, Morten A. Karsdal, Manal F. Abdelmalek
Publikováno v:
Contemporary clinical trials. 104
Background Nonalcoholic steatohepatitis (NASH) is the progressive form of nonalcoholic fatty liver disease (NAFLD); no approved therapies for NASH currently exist. Pegbelfermin (PGBF), a human fibroblast growth factor 21 analog, has metabolic effects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b91ad3deb107db005b0f33997ea70b1
https://pubmed.ncbi.nlm.nih.gov/33657443
https://pubmed.ncbi.nlm.nih.gov/33657443
Autor:
Dale Yu, George H. Klinger, Giridhar S. Tirucherai, Edgar D. Charles, J.J. van Lier, Jorg Taubel, Ratna Revankar
Publikováno v:
A37. ILD THERAPY I.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73ecebf6ae2a20177c4e279861ec4d72
https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a1492
https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a1492
Autor:
Giridhar S. Tirucherai, Jorg Taubel, Todd Correll, Ratna Revankar, Dale Yu, Jan Jaap Van Lier, George H. Klinger
Publikováno v:
Rare ILD/DPLD.
Introduction: The LPA1 receptor is implicated in IPF pathogenesis. BMS-986278 is a potent small molecule LPA1 receptor antagonist being investigated for IPF. This study evaluated the safety, tolerability, and PK of oral BMS-986278 in healthy particip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7a72975d1cace63c22ff3c954fadf34
https://doi.org/10.1183/13993003.congress-2019.pa1398
https://doi.org/10.1183/13993003.congress-2019.pa1398
Publikováno v:
Drug Development and Industrial Pharmacy. 15:1455-1473
In previous work, the use of binary drug diluent mixtures with various grades or types of microcrystalline cellulose were shown to exhibit varying degrees of release from beads prepared by extruder/marumerizer technology.In this work beads of suitabl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47b1c3098bc542f3246b98cdd61526a3
https://doi.org/10.3109/03639048909062757
https://doi.org/10.3109/03639048909062757
Publikováno v:
Drug Development and Industrial Pharmacy. 15:1311-1328
Beads prepared by extruder/marumerizer technology were formulated with water soluble drugs, microcrystalline cellulose and several waxy materials. The waxes (10 to 50% by weight) were included in an effort to slow drug release. Subsequent thermal tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb4882deca0fc2608b2182f5e14c6ca7
https://doi.org/10.3109/03639048909062747
https://doi.org/10.3109/03639048909062747
Autor:
George H. Klinger
Publikováno v:
American Journal of Health-System Pharmacy. 44:2632-2633
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46f17407b6cde4a3a22a015515e27837
https://doi.org/10.1093/ajhp/44.11.2632a
https://doi.org/10.1093/ajhp/44.11.2632a